Stock Research for CYTXW

CYTXW

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CYTXW Stock Chart & Research Data

The CYTXW chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTXW chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CYTXW Due diligence Resources & Stock Charts

The CYTXW stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYTXW Detailed Price Forecast - CNN Money CNN View CYTXW Detailed Summary - Google Finance
Yahoo View CYTXW Detailed Summary - Yahoo! Finance Zacks View CYTXW Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CYTXW Trends & Analysis - Trade-Ideas Barrons View CYTXW Major Holders - Barrons
NASDAQ View CYTXW Call Transcripts - NASDAQ Seeking View CYTXW Breaking News & Analysis - Seeking Alpha
Spotlight View CYTXW Annual Report - CompanySpotlight.com OTC Report View CYTXW OTC Short Report - OTCShortReport.com
TradeKing View CYTXW Fundamentals - TradeKing Charts View CYTXW SEC Filings - Bar Chart
WSJ View Historical Prices for CYTXW - The WSJ Morningstar View Performance/Total Return for CYTXW - Morningstar
MarketWatch View the Analyst Estimates for CYTXW - MarketWatch CNBC View the Earnings History for CYTXW - CNBC
StockMarketWatch View the CYTXW Earnings - StockMarketWatch MacroAxis View CYTXW Buy or Sell Recommendations - MacroAxis
Bullish View the CYTXW Bullish Patterns - American Bulls Short Pains View CYTXW Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CYTXW Stock Mentions - StockTwits PennyStocks View CYTXW Stock Mentions - PennyStockTweets
Twitter View CYTXW Stock Mentions - Twitter Invest Hub View CYTXW Investment Forum News - Investor Hub
Yahoo View CYTXW Stock Mentions - Yahoo! Message Board Seeking Alpha View CYTXW Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CYTXW - SECform4.com Insider Cow View Insider Transactions for CYTXW - Insider Cow
CNBC View CYTXW Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYTXW - OTC Markets
Yahoo View Insider Transactions for CYTXW - Yahoo! Finance NASDAQ View Institutional Holdings for CYTXW - NASDAQ


Stock Charts

FinViz View CYTXW Stock Insight & Charts - FinViz.com StockCharts View CYTXW Investment Charts - StockCharts.com
BarChart View CYTXW Stock Overview & Charts - BarChart Trading View View CYTXW User Generated Charts - Trading View


Latest Financial News for CYTXW

Here’s Why Cytori Therapeutics Inc (CYTX) Shares Skyrocketed Today
Posted on Friday January 05, 2018

Cytori Therapeutics Inc (NASDAQ:CYTX) was Wall Street's bull of the day today with shares that flew 74%. The cause of all the enthusiastic commotion? Japanese drug giant Takeda Pharmaceutical intends to acquire TiGenix, an advanced biopharmaceutical company developing novel stem cell therapies for serious medical conditions, at an acquisition price of EUR 1.78 per share, representing a transaction value of approximately EUR 520 million on a fully diluted basis. Investors see the acquisition of Tigenix as a positive "interest" signal for the regenerative medicine space and specifically for Cytori which has a similar adipose based product.


Cytori Therapeutics Inc’s (CYTX) Earnings Declined 36.4%, But How Did It Fare Against The Industry?
Posted on Thursday November 30, 2017

Understanding Cytori Therapeutics Inc’s (NASDAQ:CYTX) performance as a company requires examining more than earnings from one point in time. Today I will take you through a basic sense check toRead More...


Cytori reports 2Q loss
Posted on Thursday August 10, 2017

On a per-share basis, the San Diego-based company said it had a loss of 19 cents. Losses, adjusted for amortization costs, were 18 cents per share. The developer of cell therapies posted revenue of $1.5 ...


Analysts Remain Buyers of 2 Volatile Healthcare Stocks: Cytori Therapeutics Inc (CYTX) and TearLab Corp (TEAR)
Posted on Monday July 24, 2017

Cytori Therapeutics Inc: Should You Catch This Falling Knife? Cytori Therapeutics Inc (NASDAQ:CYTX) shares are crashing over 60% in Monday's trading session, after the biotech company disclosed that its pivotal STAR study assessing Habeo Cell Therapy for the treatment of scleroderma failed to achieve its primary endpoint at week 24 nor any of its secondary endpoints at week 24 or week 48. Kolbert noted, "The totality of the data combined with the investigator comments matter and suggest to us that there maybe a window for approval based on the current data set and/or a small bridging study.


Enter a stock symbol to view the stock details.